Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sherene Loi

Showing results (111-120 of 325) with videos related to

Pageof 33
Sort By:
Breast (Edinburgh, Scotland)|July 17, 2021
Tumour-infiltrating lymphocytes in non-invasive breast cancer: A systematic review and meta-analysisRafael Caparica, Marco Bruzzone, Elisa Agostinetto, et al.
JCO Precision Oncology|June 7, 2024
Efficacy and Safety of Immune Checkpoint Blockade in Patients With Li-Fraumeni SyndromeMichele Bottosso, Benjamin Verret, Olivier Caron, et al.
Journal of the National Cancer Institute|September 17, 2020
Circulating Tumor DNA Markers for Early Progression on Fulvestrant With or Without Palbociclib in ER+ Advanced Breast CancerBen O'Leary, Rosalind J Cutts, Xin Huang, et al.
Medicine and Science in Sports and Exercise|March 5, 2019
Persistent Impairment in Cardiopulmonary Fitness after Breast Cancer ChemotherapyStephen J Foulkes, Erin J Howden, Ashley Bigaran, et al.
Asia-Pacific Journal of Clinical Oncology|July 20, 2019
Efficacy of late line pertuzumab with trastuzumab and chemotherapy in HER2-positive metastatic breast cancer: An Australian case seriesAlice R T Bergin, Stephen J Luen, Peter Savas, et al.
NPJ Breast Cancer|October 21, 2024
Sustained lymphocyte decreases after treatment for early breast cancerJulia Dixon-Douglas, Balaji Virassamy, Kylie Clarke, et al.
Breast Cancer Research : BCR|December 4, 2016
An immune stratification reveals a subset of PD-1/LAG-3 double-positive triple-negative breast cancersGiulia Bottai, Carlotta Raschioni, Agnese Losurdo, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|December 12, 2022
Tumor P70S6K hyperactivation is inversely associated with tumor-infiltrating lymphocytes in triple-negative breast cancerRebeca Jimeno, Silvana Mouron, Roberto Salgado, et al.
Clinical Chemistry|September 26, 2019
Comparison of BEAMing and Droplet Digital PCR for Circulating Tumor DNA AnalysisBen O'Leary, Sarah Hrebien, Matthew Beaney, et al.
Cancer Immunology Research|August 30, 2017
Neoadjuvant Interferons: Critical for Effective PD-1-Based Immunotherapy in TNBCNatasha K Brockwell, Katie L Owen, Damien Zanker, et al.
Pageof 33

Showing results (111-120 of 325) with videos related to

Sort By:
Pageof 33
Breast (Edinburgh, Scotland)|July 17, 2021
Tumour-infiltrating lymphocytes in non-invasive breast cancer: A systematic review and meta-analysisRafael Caparica, Marco Bruzzone, Elisa Agostinetto, et al.
JCO Precision Oncology|June 7, 2024
Efficacy and Safety of Immune Checkpoint Blockade in Patients With Li-Fraumeni SyndromeMichele Bottosso, Benjamin Verret, Olivier Caron, et al.
Journal of the National Cancer Institute|September 17, 2020
Circulating Tumor DNA Markers for Early Progression on Fulvestrant With or Without Palbociclib in ER+ Advanced Breast CancerBen O'Leary, Rosalind J Cutts, Xin Huang, et al.
Medicine and Science in Sports and Exercise|March 5, 2019
Persistent Impairment in Cardiopulmonary Fitness after Breast Cancer ChemotherapyStephen J Foulkes, Erin J Howden, Ashley Bigaran, et al.
Asia-Pacific Journal of Clinical Oncology|July 20, 2019
Efficacy of late line pertuzumab with trastuzumab and chemotherapy in HER2-positive metastatic breast cancer: An Australian case seriesAlice R T Bergin, Stephen J Luen, Peter Savas, et al.
NPJ Breast Cancer|October 21, 2024
Sustained lymphocyte decreases after treatment for early breast cancerJulia Dixon-Douglas, Balaji Virassamy, Kylie Clarke, et al.
Breast Cancer Research : BCR|December 4, 2016
An immune stratification reveals a subset of PD-1/LAG-3 double-positive triple-negative breast cancersGiulia Bottai, Carlotta Raschioni, Agnese Losurdo, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|December 12, 2022
Tumor P70S6K hyperactivation is inversely associated with tumor-infiltrating lymphocytes in triple-negative breast cancerRebeca Jimeno, Silvana Mouron, Roberto Salgado, et al.
Clinical Chemistry|September 26, 2019
Comparison of BEAMing and Droplet Digital PCR for Circulating Tumor DNA AnalysisBen O'Leary, Sarah Hrebien, Matthew Beaney, et al.
Cancer Immunology Research|August 30, 2017
Neoadjuvant Interferons: Critical for Effective PD-1-Based Immunotherapy in TNBCNatasha K Brockwell, Katie L Owen, Damien Zanker, et al.
Pageof 33